
Sign up to save your podcasts
Or


We discuss the 12 month results of the Phase I Davio Trial of an innovative TKI agent for the sustained treatment of neovascular AMD with Dr. Rishi Singh, Professor of Ophthalmology, Cole Eye Insitute, President, Cleveland Cllinic-Martin Hospital, Stuart, Florida.
By Retina Synthesis4.5
88 ratings
We discuss the 12 month results of the Phase I Davio Trial of an innovative TKI agent for the sustained treatment of neovascular AMD with Dr. Rishi Singh, Professor of Ophthalmology, Cole Eye Insitute, President, Cleveland Cllinic-Martin Hospital, Stuart, Florida.

18 Listeners

2,445 Listeners

112,683 Listeners

670 Listeners

56,469 Listeners

595 Listeners

4 Listeners

11 Listeners

52 Listeners

10 Listeners

18 Listeners

1 Listeners

0 Listeners

708 Listeners